Intersect ENT, Inc. (XENT) .
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 25/100 0/7 개 기준 통과.
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2012 | $-0.94 | $5.86M | $-16.37M | -279.1% |
| 2013 | $-1.17 | $17.93M | $-18.37M | -102.4% |
| 2014 | $-1.61 | $38.59M | $-18.36M | -47.6% |
| 2015 | $-1.02 | $61.59M | $-26.63M | -43.2% |
| 2016 | $-0.89 | $78.71M | $-25.22M | -32% |
| 2017 | $-0.56 | $96.3M | $-16.36M | -17% |
| 2018 | $-0.76 | $108.47M | $-22.92M | -21.1% |
| 2019 | $-1.37 | $109.14M | $-42.99M | -39.4% |
| 2020 | $-2.22 | $80.55M | $-72.32M | -89.8% |
| 2021 | $-4.80 | $106.75M | $-159.64M | -149.5% |
